ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

Agricultural Pesticide Use Linked To Prostate Cancer

July 25, 2003

House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention

July 20, 1990

“Flat” Administrative Structure To Include Resource Teams

September 15, 1995

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002

Roswell Park’s Future “Bright” As Center Snares Leading Scientists, Hohn Says.

January 18, 2002